Knowledge, perceptions and uptake of human papilloma virus vaccine among adolescent girls in Kampala, Uganda; a mixed-methods school-based study.
10–14 years
Adolescent girls
HPV vaccine
Knowledge
Perceptions
Uptake
Journal
BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804
Informations de publication
Date de publication:
17 07 2023
17 07 2023
Historique:
received:
28
07
2022
accepted:
03
07
2023
medline:
19
7
2023
pubmed:
18
7
2023
entrez:
17
7
2023
Statut:
epublish
Résumé
Cervical cancer is a major public health challenge, accounting for substantial morbidity and mortality. Human Papilloma Virus (HPV) vaccination is the recommended primary public health intervention for HPV infection prevention. However, there's limited evidence on the level of knowledge, attitude, and practices of adolescent girls regarding HPV vaccination in Kampala city, Uganda. This study assessed the knowledge, perceptions, and practices of adolescent girls aged 10-14 years towards HPV vaccination program in Kampala, Uganda to generate evidence to guide programs targeted at improving uptake of the vaccine. A convergent parallel mixed methods study was conducted in Kampala, Uganda. A structured questionnaire was used to elicit data from 524 adolescent girls. In addition, 6 Focus group discussions, and 24 key informant interviews (teacher and parents) were conducted. Multistage and purposive sampling techniques were used to select quantitative and qualitative participants respectively. Quantitative data were entered using epidata, cleaned and analyzed using Stata v14 while qualitative data were analyzed using thematic content analysis in atlas ti version 8. Overall, only 8.6% (45/524) of the girls had completed the HPV vaccine schedule of two dozes, 49.2% (258/524) of the girls had low knowledge about the HPV vaccine and teachers and parents affirmed this lack of knowledge among adolescent girls especially concerning the target age group, dosage, and vaccine interval. About 51.9% (272/524) of girls had negative perceptions towards HPV vaccination. Parents expressed negative perceptions, beliefs, superstitions, and safety concerns of the vaccine.Girls residing in rural areas (adjusted prevalence ratio, aPR = 0.35, C. I = 0.14-0.85) had lower knowledge levels compared to those in urban areas. Girls whose mothers were healthcare providers (aPR = 1.94, C. I = 1.10-3.41), girls with high knowledge levels (aPR = 1.79, C. I = 1.21-2.63) and positive perceptions (aPR = 2.87, C. I = 1.93-4.27) had a higher prevalence of being fully vaccinated. Girls generally had low levels of knowledge, negative perceptions, and poor uptake of HPV vaccination. We recommend sensitization campaigns in schools and communities to improve awareness, perceptions, and practices of stakeholders towards HPV vaccination.
Sections du résumé
BACKGROUND
Cervical cancer is a major public health challenge, accounting for substantial morbidity and mortality. Human Papilloma Virus (HPV) vaccination is the recommended primary public health intervention for HPV infection prevention. However, there's limited evidence on the level of knowledge, attitude, and practices of adolescent girls regarding HPV vaccination in Kampala city, Uganda. This study assessed the knowledge, perceptions, and practices of adolescent girls aged 10-14 years towards HPV vaccination program in Kampala, Uganda to generate evidence to guide programs targeted at improving uptake of the vaccine.
METHODS
A convergent parallel mixed methods study was conducted in Kampala, Uganda. A structured questionnaire was used to elicit data from 524 adolescent girls. In addition, 6 Focus group discussions, and 24 key informant interviews (teacher and parents) were conducted. Multistage and purposive sampling techniques were used to select quantitative and qualitative participants respectively. Quantitative data were entered using epidata, cleaned and analyzed using Stata v14 while qualitative data were analyzed using thematic content analysis in atlas ti version 8.
RESULTS
Overall, only 8.6% (45/524) of the girls had completed the HPV vaccine schedule of two dozes, 49.2% (258/524) of the girls had low knowledge about the HPV vaccine and teachers and parents affirmed this lack of knowledge among adolescent girls especially concerning the target age group, dosage, and vaccine interval. About 51.9% (272/524) of girls had negative perceptions towards HPV vaccination. Parents expressed negative perceptions, beliefs, superstitions, and safety concerns of the vaccine.Girls residing in rural areas (adjusted prevalence ratio, aPR = 0.35, C. I = 0.14-0.85) had lower knowledge levels compared to those in urban areas. Girls whose mothers were healthcare providers (aPR = 1.94, C. I = 1.10-3.41), girls with high knowledge levels (aPR = 1.79, C. I = 1.21-2.63) and positive perceptions (aPR = 2.87, C. I = 1.93-4.27) had a higher prevalence of being fully vaccinated.
CONCLUSION
Girls generally had low levels of knowledge, negative perceptions, and poor uptake of HPV vaccination. We recommend sensitization campaigns in schools and communities to improve awareness, perceptions, and practices of stakeholders towards HPV vaccination.
Identifiants
pubmed: 37461002
doi: 10.1186/s12887-023-04174-z
pii: 10.1186/s12887-023-04174-z
pmc: PMC10351135
doi:
Substances chimiques
Papillomavirus Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
368Informations de copyright
© 2023. The Author(s).
Références
J Rural Health. 2019 Jun;35(3):405-417
pubmed: 30444935
Public Health. 2014 Mar;128(3):268-73
pubmed: 24529635
PLoS One. 2013;8(2):e56402
pubmed: 23431375
J Fam Plann Reprod Health Care. 2014 Jan;40(1):14-22
pubmed: 23902714
Stat Methods Med Res. 2013 Dec;22(6):661-70
pubmed: 22072596
J Fam Plann Reprod Health Care. 2011 Jan;37(1):22-5
pubmed: 21367699
BMC Womens Health. 2020 Jul 13;20(1):145
pubmed: 32660461
J Cancer Educ. 2021 Jun;36(3):584-590
pubmed: 31840211
Br J Cancer. 2005 May 9;92(9):1808-12
pubmed: 15827554
Hum Vaccin Immunother. 2013 Feb;9(2):300-5
pubmed: 23111121
PLoS One. 2019 Aug 6;14(8):e0220545
pubmed: 31386684
Womens Health Issues. 2010 Jan-Feb;20(1):28-34
pubmed: 20123174
Vaccine. 2013 Feb 4;31(7):1051-6
pubmed: 23277094
Pan Afr Med J. 2018 Nov 15;31:184
pubmed: 31086634
Oncol Lett. 2020 Sep;20(3):2058-2074
pubmed: 32782524
Vaccine. 2009 Apr 28;27(19):2625-9
pubmed: 19428869
Asian Pac J Cancer Prev. 2018 Apr 27;19(4):1105-1111
pubmed: 29699371
Stat Med. 2016 Dec 30;35(30):5730-5735
pubmed: 27460748
Am J Epidemiol. 2004 Apr 1;159(7):702-6
pubmed: 15033648
Asian Pac J Cancer Prev. 2014;15(17):7263-6
pubmed: 25227825
Am J Epidemiol. 2011 Oct 15;174(8):984-92
pubmed: 21841157